NAMS
Price
$35.65
Change
-$0.30 (-0.83%)
Updated
Dec 24 closing price
Capitalization
4.04B
69 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$9.18
Change
+$0.11 (+1.21%)
Updated
Dec 24 closing price
Capitalization
655.07M
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NAMS vs VTYX

Header iconNAMS vs VTYX Comparison
Open Charts NAMS vs VTYXBanner chart's image
NewAmsterdam Pharma
Price$35.65
Change-$0.30 (-0.83%)
Volume$310.43K
Capitalization4.04B
Ventyx Biosciences
Price$9.18
Change+$0.11 (+1.21%)
Volume$593.31K
Capitalization655.07M
NAMS vs VTYX Comparison Chart in %
NAMS
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NAMS vs. VTYX commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (NAMS: $35.65 vs. VTYX: $9.18)
Brand notoriety: NAMS and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 31% vs. VTYX: 11%
Market capitalization -- NAMS: $4.04B vs. VTYX: $655.07M
NAMS [@Biotechnology] is valued at $4.04B. VTYX’s [@Biotechnology] market capitalization is $655.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAMS and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 4 bearish.
  • VTYX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than VTYX.

Price Growth

NAMS (@Biotechnology) experienced а +5.85% price change this week, while VTYX (@Biotechnology) price change was +19.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

NAMS is expected to report earnings on Mar 04, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($4.04B) has a higher market cap than VTYX($655M). VTYX YTD gains are higher at: 319.178 vs. NAMS (38.716). VTYX has higher annual earnings (EBITDA): -115.4M vs. NAMS (-268.03M). NAMS has more cash in the bank: 703M vs. VTYX (193M). NAMS has less debt than VTYX: NAMS (266K) vs VTYX (10M). NAMS has higher revenues than VTYX: NAMS (35.2M) vs VTYX (0).
NAMSVTYXNAMS / VTYX
Capitalization4.04B655M617%
EBITDA-268.03M-115.4M232%
Gain YTD38.716319.17812%
P/E RatioN/AN/A-
Revenue35.2M0-
Total Cash703M193M364%
Total Debt266K10M3%
TECHNICAL ANALYSIS
Technical Analysis
NAMSVTYX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNGAX60.420.26
+0.43%
American Funds New Economy R1
LCSTX27.570.08
+0.29%
ClearBridge Sustainability Leaders FI
VDSYX24.550.05
+0.20%
Victory Diversified Stock Y
SMVFX11.270.02
+0.18%
Virtus Ceredex Mid-Cap Value Equity C
BFGIX61.59-0.07
-0.11%
Baron Focused Growth Institutional

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-0.83%
IDYA - NAMS
47%
Loosely correlated
+0.76%
IMVT - NAMS
46%
Loosely correlated
+0.45%
CRNX - NAMS
45%
Loosely correlated
-0.33%
ROIV - NAMS
43%
Loosely correlated
+0.22%
XENE - NAMS
41%
Loosely correlated
+1.06%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+1.21%
KYMR - VTYX
40%
Loosely correlated
-0.48%
REPL - VTYX
38%
Loosely correlated
+3.81%
NAMS - VTYX
38%
Loosely correlated
-0.83%
DSGN - VTYX
37%
Loosely correlated
+1.46%
VRDN - VTYX
35%
Loosely correlated
+0.53%
More